| AIS | adenocarcinoma in situ |
| AUC | areas under the curve |
| CI | confidence intervals |
| CIN | cervical intraepithelial neoplasia |
| CIN1 | cervical intraepithelial neoplasia grade 1 |
| CIN | cervical intraepithelial neoplasia grade 2 |
| CIN2+ | cervical intraepithelial neoplasia grade 2, grade 3 and cancer |
| CIN3 | cervical intraepithelial neoplasia grade 3 |
| CIN3+ | cervical intraepithelial neoplasia grade 3 and cancer |
| DNA | deoxyribonucleic acid |
| E1 | early gene 1 |
| E7 | early gene 7 |
| FDR | false discovery rate |
| FFPE | formalin fixed paraffin-embedded |
| HC2 | Hybrid Capture 2 |
| HPV | Human papillomavirus |
| HPV31 | Human papillomavirus type 31 |
| HR | high-risk |
| IARC | International Agency for Research on Cancer |
| ICC | invasive cervical cancer |
| KPNC | Kaiser Permanente Northern California |
| L1 | late gene 1 |
| MAF | minor allele frequency |
| MRCA | most recent common ancestor |
| NCI | National Cancer Institute |
| OR | odds ratio |
| PaP | Persistence and Progression |
| PCR | polymerase chain reaction |
| ROC | Receiver operating characteristic |
| SNPs | single nucleotide polymorphisms |
| STM | specimen transport medium |
| vs. | versus |